Oncaspar European Union - English - EMA (European Medicines Agency)

oncaspar

les laboratoires servier - pegaspargase - precursor cell lymphoblastic leukemia-lymphoma - antineoplastic agents, - oncaspar is indicated as a component of antineoplastic combination therapy in acute lymphoblastic leukaemia (all) in paediatric patients from birth to 18 years, and adult patients.,

Mitomycin medac 20 mg powder and solvent for intravesical solution Ireland - English - HPRA (Health Products Regulatory Authority)

mitomycin medac 20 mg powder and solvent for intravesical solution

medac gesellschaft fur klinische spezialpraparate mbh - mitomycin - pdr+solv/soln/intravesical use - 20 milligram(s) - other cytotoxic antibiotics; mitomycin

Hepa-Merz infusion concentrate 0.5g/ml Malta - English - Medicines Authority

hepa-merz infusion concentrate 0.5g/ml

merz pharmaceuticals gmbh eckenheimer landstrasse 100, d-60318 frankfurt am main, germany - l, ornithine, aspartate - concentrate for solution for infusion - l-ornithine 5 g/ml l-aspartate 5 g/ml - bile and liver therapy